HELSINKI, Finland, December, 2020 – Euformatics, a world-leader in NGS data quality control applications and variant interpretation solutions, has agreed an exclusive distribution agreement with DYNEX TECHNOLOGIES, spol. s r.o. (DYNEX) for its innovative bioinformatics software solutions in the Czech Republic.
“Euformatics is excited to build this new partnership with DYNEX where they will play an important role in our mission of accelerating the transition to precision medicine. We are looking forward to making the most of DYNEX’s strong network of medical leaders in the region, and providing the tools laboratories need to get the most out of their NGS data. The experience DYNEX has in this area is something which we are keen to capitalise on to ensure that we build strong and long-lasting relationships” emphasised Tommi Kaasalainen, Euformatics CEO.
“Our partnership with Euformatics gives us a very strong offering for our customers who are using Next Generation Sequencing methods. Based on our evaluation of different bioinformatics applications for Next Generation Sequencing we concluded that omnomicsQ and omnomicsNGS are the best tools for quality control and variant interpretation for labs doing clinical genetics. As more laboratories in the Czech Republic transition to NGS technology, we are ready with the software solutions that they need to get the most out of their data” commented DYNEX Managing Director, Zora Hanzlíková.
The agreement covers Euformatics’ omnomics Suite of genomic data software solutions, including world-leading quality control tool omnomicsQ, as well as its CE-marked variant interpretation and reporting tool, omnomicsNGS.
DYNEX is one of the largest suppliers of laboratory equipment and related services in the Czech Republic and Slovakia. Its primary focus is the sale of instruments, diagnostics, and other reagents for immunochemical, molecular-biological, and microbiological laboratories. Our customers are not only clinical laboratories and scientific workplaces, but also transfusion centers, forensic laboratories, food, plant, and veterinary laboratories. DYNEX has a broad specialization, including Next-Generation Sequencing, ELISA, immuno-blot and western-blot, immunofluorescence assay (IFA), PCR, hybridization, electrophoresis, microarray, lateral-flow immunoassay (LFIA), immunoprecipitation, cultivation, and cell growth curves measurements.
Since 2004 DYNEX has been focusing on the research and development of new laboratory devices and diagnostics. DYNEX has its own R&D team and is cooperating with many of the most important and prestigious scientific institutions in the Czech Republic and Slovakia.
Euformatics is a Finnish software company that specialises in high standard bioinformatics tools for genomic data interpretation. Since 2010, Euformatics has been helping medical doctors and molecular genetics laboratories provide better precision medicine for cancer, common or rare disease diagnostics. At present, our core solution is the omnomics Suite which includes omnomicsNGS; for clinical analysis of patient NGS data, and omnomicsQ; for NGS data quality management.